StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Xeris Pharmaceuticals Inc. (XERS)

Form 4 XERIS PHARMACEUTICALS For: Jan 13 Filed by: PRESTRELSKI STEVEN January 15, 2021 4:04 PM - SEC Filing Form 4 XERIS PHARMACEUTICALS For: Jan 11 Filed by: PRESTRELSKI STEVEN January 12, 2021 4:03 PM - SEC Filing Xeris Pharmaceuticals to Participate in H.C. Wainwright BioConnect 2021 Virtual Conference January 5, 2021 4:05 PM - BizWire Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) December 31, 2020 4:05 PM - BizWire Xeris Pharmaceuticals (XERS) Announces Distribution Agreement With Megapharm Ltd. to Commercialize Gvoke in Israel and the Palestinian Authority December 22, 2020 7:06 AM - StreetInsider Xeris Pharmaceuticals Announces Distribution Agreement With Megapharm Ltd. to Commercialize Gvoke® in Israel and the Palestinian Authority December 22, 2020 7:00 AM - BizWire Form 4 XERIS PHARMACEUTICALS For: Dec 16 Filed by: PRESTRELSKI STEVEN December 17, 2020 4:40 PM - SEC Filing Xeris Pharmaceuticals (XERS) Board Member Mark Thierer to Resign December 17, 2020 4:16 PM - StreetInsider Form 8-K XERIS PHARMACEUTICALS For: Dec 17 December 17, 2020 4:06 PM - SEC Filing Form 8-K XERIS PHARMACEUTICALS For: Dec 14 December 14, 2020 5:02 PM - SEC Filing Form SC TO-I/A XERIS PHARMACEUTICALS Filed by: XERIS PHARMACEUTICALS INC December 14, 2020 5:00 PM - SEC Filing Xeris Pharmaceuticals Receives Positive CHMP Opinion for Ogluo™, Its Ready-To-Use (RTU) Glucagon for Injection, for the Treatment of Severe Hypoglycaemia in Adults, Adolescents, and Children Aged 2 December 11, 2020 4:00 AM - BizWire Form 4 XERIS PHARMACEUTICALS For: Dec 09 Filed by: Edick Paul R December 10, 2020 4:53 PM - SEC Filing Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) November 27, 2020 1:05 PM - BizWire Form 8-K XERIS PHARMACEUTICALS For: Nov 16 November 16, 2020 7:26 AM - SEC Filing Form SC TO-I XERIS PHARMACEUTICALS Filed by: XERIS PHARMACEUTICALS INC November 10, 2020 5:28 PM - SEC Filing Form 10-Q XERIS PHARMACEUTICALS For: Sep 30 November 9, 2020 4:02 PM - SEC Filing Form 8-K XERIS PHARMACEUTICALS For: Nov 09 November 9, 2020 7:05 AM - SEC Filing Xeris Pharmaceuticals Inc. (XERS) Tops Q3 EPS by 17c, Revenues Beat November 9, 2020 7:00 AM - StreetInsider Xeris Pharmaceuticals Reports Third Quarter 2020 Financial Results and Corporate Highlights November 9, 2020 7:00 AM - BizWire Xeris Pharmaceuticals to Announce Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020 November 2, 2020 7:00 AM - BizWire Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) October 30, 2020 4:05 PM - BizWire Full Article List